Page last updated: 2024-08-17

uridine diphosphate and transforming growth factor beta

uridine diphosphate has been researched along with transforming growth factor beta in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Bayliss, MT; Dudhia, J; Edwards, JC; Hickery, MS; Lewthwaite, JC; Pitsillides, AA1
Ide, T; Inoue, K; Kurose, H; Nagao, T; Nakaya, M; Narita, Y; Nishida, M; Sato, Y; Suzuki, K; Tozaki-Saitoh, H; Uemura, A1
Hori, M; Murata, T; Nakamura, T; Ozaki, H1
Chen, C; Cheng, B; Gao, Q; Huang, A; Huang, L; Lei, C; Li, J; Li, X; Lin, X; Nie, D; Tang, N; Wang, K1

Other Studies

4 other study(ies) available for uridine diphosphate and transforming growth factor beta

ArticleYear
Age-related changes in the response of human articular cartilage to IL-1alpha and transforming growth factor-beta (TGF-beta): chondrocytes exhibit a diminished sensitivity to TGF-beta.
    The Journal of biological chemistry, 2003, Dec-26, Volume: 278, Issue:52

    Topics: Adolescent; Adult; Aged; Aging; Cartilage; Cartilage, Articular; Cells, Cultured; Chondrocytes; Chondroitin Sulfates; Gene Expression Regulation; Glycosaminoglycans; Humans; Interleukin-1; Middle Aged; Proteoglycans; Recombinant Proteins; Sulfates; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Uridine Diphosphate; Uridine Diphosphate Glucose Dehydrogenase

2003
P2Y6 receptor-Galpha12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis.
    The EMBO journal, 2008, Dec-03, Volume: 27, Issue:23

    Topics: Adenosine Triphosphate; Animals; Blood Pressure; Cell Adhesion Molecules; Connective Tissue Growth Factor; Fibrosis; Gene Expression; GTP-Binding Protein alpha Subunits, G12-G13; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Peptidyl-Dipeptidase A; Purinergic P2 Receptor Antagonists; Rats; Receptors, Purinergic P2; Signal Transduction; Transforming Growth Factor beta; Uridine Diphosphate

2008
UDP induces intestinal epithelial migration via the P2Y6 receptor.
    British journal of pharmacology, 2013, Volume: 170, Issue:4

    Topics: Animals; Cell Line; Cell Movement; Dose-Response Relationship, Drug; Epithelial Cells; Intestinal Mucosa; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Rats; Receptor, Transforming Growth Factor-beta Type I; Receptors, Purinergic P2; Receptors, Transforming Growth Factor beta; Signal Transduction; Time Factors; Transforming Growth Factor beta; Uridine Diphosphate; Wound Healing

2013
Dysregulated glucuronic acid metabolism exacerbates hepatocellular carcinoma progression and metastasis through the TGFβ signalling pathway.
    Clinical and translational medicine, 2022, Volume: 12, Issue:8

    Topics: Animals; Carcinoma, Hepatocellular; Glucuronic Acid; Glutathione Transferase; Humans; Liver Neoplasms; Mice; RNA, Messenger; Transforming Growth Factor beta; Uridine Diphosphate; Uridine Diphosphate Glucose Dehydrogenase

2022